IRIS
ROSSI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.224
AS - Asia 4.597
EU - Europa 3.199
SA - Sud America 643
AF - Africa 199
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 13.880
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.100
SG - Singapore 1.697
CN - Cina 1.356
VN - Vietnam 680
IE - Irlanda 568
BR - Brasile 517
SE - Svezia 513
FI - Finlandia 454
IT - Italia 446
HK - Hong Kong 358
DE - Germania 312
UA - Ucraina 248
FR - Francia 178
NL - Olanda 143
TR - Turchia 136
ZA - Sudafrica 134
GB - Regno Unito 91
CA - Canada 70
IN - India 69
RU - Federazione Russa 63
AR - Argentina 51
AT - Austria 44
IQ - Iraq 37
ID - Indonesia 36
MX - Messico 35
BE - Belgio 34
KR - Corea 34
ES - Italia 29
BD - Bangladesh 28
JP - Giappone 25
CZ - Repubblica Ceca 21
MA - Marocco 19
EC - Ecuador 18
PL - Polonia 18
PK - Pakistan 16
TH - Thailandia 14
PY - Paraguay 13
PE - Perù 12
CO - Colombia 11
UZ - Uzbekistan 11
EG - Egitto 10
MY - Malesia 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
TW - Taiwan 9
AZ - Azerbaigian 8
JO - Giordania 8
AU - Australia 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
VE - Venezuela 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
KE - Kenya 6
CL - Cile 5
DZ - Algeria 5
LB - Libano 5
NP - Nepal 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
UY - Uruguay 5
ET - Etiopia 4
IL - Israele 4
IR - Iran 4
LT - Lituania 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
HU - Ungheria 3
NG - Nigeria 3
TN - Tunisia 3
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
RS - Serbia 2
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 13.873
Salva come PNG Salva come JPEG
Città #
Singapore 872
Ashburn 708
Chandler 613
Dublin 565
San Jose 445
Santa Clara 395
Hong Kong 341
Beijing 319
Jacksonville 310
Dallas 239
Ho Chi Minh City 222
Dearborn 212
Ann Arbor 162
Hanoi 150
Boardman 149
Parma 138
Nanjing 131
Johannesburg 122
Izmir 104
Princeton 103
Lauterbourg 98
Los Angeles 95
Shanghai 86
Wilmington 76
San Mateo 71
Hefei 68
Helsinki 67
Shenyang 61
Munich 60
Nanchang 59
Council Bluffs 53
New York 52
Columbus 50
Toronto 45
Bremen 40
São Paulo 40
Seattle 38
Milan 37
Moscow 35
Hebei 34
Brussels 33
Buffalo 33
The Dalles 33
Vienna 33
Jinan 32
Woodbridge 32
Da Nang 31
Guangzhou 31
Bologna 29
Brooklyn 27
Changsha 26
Jiaxing 26
Kunming 26
Haiphong 25
Seoul 25
Tianjin 24
Jakarta 23
Des Moines 22
Frankfurt am Main 20
Brno 18
Rio de Janeiro 18
Tokyo 18
Houston 17
Amsterdam 16
Falls Church 15
Norwalk 15
Orem 15
Baghdad 14
London 14
Nuremberg 14
Phoenix 14
Turku 14
Chicago 13
Fremont 13
Rome 13
Turin 13
Warsaw 13
Grafing 12
Stockholm 12
Brasília 11
Denver 11
Zhengzhou 11
Ankara 10
Can Tho 10
Taizhou 10
Atlanta 9
Belo Horizonte 9
Boston 9
Campinas 9
Hải Dương 9
Manchester 9
Montreal 9
Poplar 9
Pune 9
Baku 8
Dong Ket 8
Hangzhou 8
Lahore 8
Mexico City 8
Padova 8
Totale 8.479
Salva come PNG Salva come JPEG
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 244
Opportunity and challenges of nasal powders: Drug formulation and delivery 197
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 197
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 189
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 184
Alginate containing formulations: are they all the same? 178
Sex-specific cardiac electrophysiological remodeling influences the susceptibility to arrhythmias in elderly rats 176
MULTILAYERED PHARMACEUTICAL FORMULATION 172
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 170
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 168
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 168
Aerodynamic performance of jet nebulizers marketed in Germany 166
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 165
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 163
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 161
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 161
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 159
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 158
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 158
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 158
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 157
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 156
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 154
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 154
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 153
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 150
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 146
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 146
Interaction of pharmaceutical hydrates with supoercritical CO2: solubility, solid state and chemical modifications 145
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 144
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 143
Thermal degradation and melting point determination of diclofenac 142
Development of solid lipid microparticles by melt-emulsification/spray-drying processes as carriers for pulmonary drug delivery 141
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 136
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 135
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 134
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 134
Current status of ATP-ase proton pump inhibitor complexation with cyclodextrins 132
Thermal Properties of Binary Mixtures of b-Cyclodextrin with Carbamazepine Polymorphs 130
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 128
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 127
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 126
Primary microparticles and agglomerates of morphine for nasal insufflation 126
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide 125
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 125
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 125
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 124
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 124
Thermal and Morfological characterisation of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution 123
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 122
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 122
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 121
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 120
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 118
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 118
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 117
Layered lipid microcapsules for mesalazine delayed-release in children 116
In vitro comparison of medicinal products based on alginic acid claimed to protect the esophagus wall and physically prevent acid reflux 116
Swellable and rigid matrices: Controlled Release Matrices with Cellulose Ethers 116
Inclusion Properties, Polymorphism and Desolvation Kinetics in aNew 2-Pyridyl Iminophenol Compound with 1D Nanochannels 115
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia 114
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 114
New salt of cysteamine for the preparation of highly respirable particles 114
Particles and powders: Tools of innovation for non-invasive drug administration 112
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 112
Hesperidin Gastroresistant Microparticles by Spray-Drying: Preparation, Characterization, and Dissolution Profiles 111
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 110
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 109
Phase diagrams in the binary system 109
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 109
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 109
High Respirable Insulin Dry Powder for Pulmonary Administration 108
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 108
Lecithin/Chitosan Based Nanosystem for Tamoxifen Citrate Oral Delivery 108
Polymorphism of rac-5,6-Diisobutyryloxy-2-Methylamino-1,2,3,4-Tetrahydro-Napthalene Hydrochloride (CHF 1035). I. Thermal, Spectroscopic, and X-ray Diffraction Properties 108
Solid state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose 106
Bauhinia ungulata L.: Medicinal Utilization, Botanical Aspects, Biological Properties and Chemical Constitution Reported in the Literature 105
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 105
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 105
Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents 102
Pantoprazole Cyclodextrin Inclusion Complexes 101
New Farnesane Sesquiterpenes from Lactarius Porninsis 100
Le Basi del Calcolo Farmaceutico 100
Multi-kinetics and site-specific oral delivery system of artemether and clindamycin for malaria theraphy 99
Polymorphism in Cocoa Butter Under Shear 98
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 97
Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties 97
Influence of tamoxifen citrate loading on lecithin/chitosan nanoparticles 96
In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery 96
Nasal Powders of Morphine Microcrystal Agglomerates 95
Thermal behavior of paracetamol-polymeric excipients mixtures 95
Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles 93
New Protoilludane Sesquiterpenes from Lactarius Violascens” 92
Acai Oil-Based Organogel Containing Hyaluronic Acid for Topical Cosmetic: In Vitro and Ex Vivo Assessment 91
Conversion of carbamazepine polymorphs in supercritical CO2 91
Understanding and enhancing density distribution inside tableted Dome Matrix modules 91
The Development of Insulin Dry Powder Blends for Pulmonary Administration 90
Nasal Powders of Morphine Microcrystal Agglomerates 89
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 89
Quercetin Microspheres by Solvent Evaporation: Preparation, Characterization and Release Behavior 87
Totale 12.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 0 0 0 0 0 0 0 0 23 85 18
2021/2022603 11 13 11 28 25 25 78 89 27 42 47 207
2022/20232.154 222 246 146 167 189 236 19 142 701 19 52 15
2023/2024800 34 88 24 55 67 187 63 47 25 46 67 97
2024/20252.605 73 132 144 163 285 341 110 104 293 236 240 484
2025/20265.061 564 518 729 417 828 272 600 135 666 332 0 0
Totale 14.041